|Articles|October 1, 2019
- BioPharm International-10-01-2019
- Volume 32
- Issue 10
BioPharm International, October 2019 Issue (PDF)
Click the title above to open the BioPharm International October 2019 issue in an interactive PDF format.
Advertisement
Articles in this issue
about 6 years ago
Driving Improved Access to Biosimilarsabout 6 years ago
Technology Redefines Continuous Processing Efficiencyover 6 years ago
Image Repair Must Start with the Root Causeover 6 years ago
Best Practices for Selecting a Top-Quality Cell Lineover 6 years ago
Data Integrity Violations Draw Strong FDA Rebukesover 6 years ago
ALCOA+ and Data Integrityover 6 years ago
Using Software in Process Validationover 6 years ago
Streamlining Operations in Fill/Finishover 6 years ago
Outsourcing Early Development OperationsNewsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Advertisement
Advertisement
Advertisement
Trending on BioPharm International
1
Insuring Novel Biologic Development Against Geopolitical Developments: Part Three of Three with Abzena
2
Year in Review: How FDA Guidances Defined the 2025 Biopharma Landscape
3
Building Robust Biomanufacturing Networks for the Next Wave of Therapies
4
Top BP Videos of 2025: An Intersection of AI, Innovation, and Compliance
5
